Novel monoamine transporter ligands reduce cocaine-induced enhancement of brain stimulation reward

Pharmacology Biochemistry and Behavior

Volumn 68, Issue 1, 2001, Pages 171-180

  Trzcińska, Monika ^a   Pimentel, Patricia ^a   Stellar, James R ^a   Hanson, Robert N ^a   Choi, Sung Woon ^b   Elmaleh, David R ^b   Zhang, Jianrong ^c   Prakash, K R C ^c   Tamiz, Amir P ^c   Kozikowski, Alan P ^c   Johnson, Kenneth M ^d   Smith, Miles P ^e   Babich, John W ^e  

^a NORTHEASTERN UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^e Biostream Inc   (United States)

Author keywords

Anticocaine behavioral screen; Brain stimulation reward; GBR analogue; Phenyltropane; Piperazine; Piperidine; Reward threshold; WIN analogue

Indexed keywords

1 RV 96A; 4 ARA 42C; 5 ARA 74A; COCAINE; DOPAMINE; DOPAMINE TRANSPORTER; LIGAND; MC9 20; NOCAINE 250B; NOCAINE 3B; NORADRENALIN; NORADRENALIN TRANSPORTER; PIPERAZINE DERIVATIVE; PIPERIDINE DERIVATIVE; SEROTONIN; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG; BIOGENIC AMINE; CARRIER PROTEIN; DRUG DERIVATIVE; NEUROTRANSMITTER UPTAKE INHIBITOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REWARD; TRAINING; ANIMAL; BRAIN; ELECTROSTIMULATION; INSTRUMENTAL CONDITIONING; METABOLISM; PHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; RAT STRAIN;

ARA;

ANIMAL; BIOGENIC MONOAMINES; BRAIN; CARRIER PROTEINS; COCAINE; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; LIGANDS; MALE; NEUROTRANSMITTER UPTAKE INHIBITORS; PSYCHOMOTOR PERFORMANCE; RATS; RATS, SPRAGUE-DAWLEY; REWARD; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0035082367     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(00)00454-8     Document Type: Article

References (59)

1. Effectiveness and costs of inpatient versus day hospital cocaine. Rehabilitation
2. The biological, social and clinical bases of drug addiction, commentary and debate
3. Novel GABA agonists depress the reward effect of lateral hypothalamic stimulation in rats
4. Synergic effects of cocaine with lateral hypothalamic brain stimulation reward: Lack of tolerance or sensitization
5. Expression of a single dopamine transporter cDNA can confer two cocaine binding sites
6. GBR 12783, a potent and selective inhibitor of dopamine uptake: Biochemical studies in vivo and ex vivo
7. A microcomputer-based method for physiologically interpretable measurement of the rewarding efficacy of brain stimulation
8. Cocaine receptor: Biochemical characterization and structure-activity relationship of cocaine analogues at the dopamine transporter
9. Pharmacotherapies for treatment of cocaine abuse: Preclinical aspects
10. Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine as dopamine transporter inhibitors
11. A novel strategy for the treatment of cocaine addiction
12. Potent and selective ligands for the dopamine transporter (DAT): Structure-activity relationship studies of novel 4-[2-(diphenylmethoxy)ethyl]-1](3-phenylpropyl)piperidine analogues
13. Cocaine cross-sensitization to dopamine uptake inhibitors: Unique effects of GBR-12909
14. The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats
15. Determining the quantitative characteristics of a reward pathway
16. Cocaine addiction: Psychology and neurophysiology
17. Sustained decrease in cocaine-maintained responding in rhesus monkeys with 1-[-2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(-3-hydroxy-3-phenylpropyl) piperazinyl decanoate, a long-acting ester derivative of GBR 12909
18. Novel pharmacotherapies for cocaine abuse - 1995 to present
19. Differential relationship among dopamine transporter affinities and stimulant properties of various uptake inhibitors
20. 3H]mazindol binding sites from alkylation by N-ethylmaleimide
21. Effects of GBR 12909, a selective dopamine uptake inhibitor, on motor activity and operant behavior in the rat
22. Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding
23. Research issues related to development of medications for treatment of cocaine addiction
24. 3′-chloro-3a-(diphenylmethoxy)tropane, but not 4′-chloro-3a-(diphenylmethoxy)tropane produces a cocaine-like behavioral profile
25. Chemistry and pharmacology of the piperidine-based analogues of cocaine. Identification of potent DAT inhibitors lacking the tropane skeleton
26. The effects of putative 5-hydroxytryptamine receptor active agents on D-amphetamine self-administration in controls and rats with 5,7-dihydroxytryptamine medial forebrain bundle lesions
27. Acute and chronic fluoxetine treatment decreases the sensitivity of rats to rewarding brain stimulation
28. Oxygenated analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12935 and GBR 12909) as potential extended-action cocaine-abuse therapeutic agents
29. Differential effects of withdrawal from chronic amphetamine or fluoxetine administration on brain stimulation reward in the rat-interactions between the two drugs
30. Dopamine transporter: Transmembrane phenylalanine mutations can selectively influence dopamine update and cocaine analog recognition
31. Increased self-administration of D-amphetamine after destruction of 5-hydroxytryptaminergic neurons
32. Effects of cocaine and GBR-12909 on brain stimulation reward
33. The effects of long-term administration of antidepressant drugs on intracranial self-stimulation responding in rats
34. Management of cocaine abuse and dependence
35. The curve-shift paradigm in self-stimulation
36. Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation behavior in rats
37. Novel 3a-(diphenylmethoxy)tropane analogs: Potent dopamine uptake inhibitors without cocaine-like behavioral profiles
38. Testing novel anti-cocaine drugs MC9-20 and nocaine-B with a rate-frequency brain stimulation reward enhancement paradigm
39. Effects of novel piperidines on cocaine-induced enhancement of reward - Brain Stimulation Reward Study
40. N-Phenylalkyl-substituted tropane analogs of boat conformation with high selectivity for the dopamine versus serotonin transporter
41. Cocaine receptors on dopamine transporter are related to self-administration of cocaine
42. The neural basis of drug craving: An incentive-sensitization theory of addiction
43. High affinity dopamine reuptake inhibitors as potential cocaine antagonists: A strategy for drug development
44. Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior
45. Methoxylation of cocaine reduces binding affinity and produces compounds of differential binding and dopamine uptake inhibitory activity: Discovery of a weak cocaine "antagonist"
46. Dopaminergic agents for the treatment of cocaine abuse
47. Pharmacological basis of intracranial self-stimulation reward
48. Effects of peripheral and central dopamine blockage on lateral hypothalamic self-stimulation: Evidence for both reward and motor deficits
49. Neonatal dopamine depletions spare lateral hypothalamic stimulation reward in adult rats
50. Application of the bivalent ligand approach to the design of novel dimeric serotonin reuptake inhibitors
51. Differential reinforcing effects of cocaine and GBR-12909: Biochemical evidence for divergent neuroadaptive changes in the mesolimbic dopaminergic system
52. Chronic DMI reduces thresholds for brain stimulation reward in the rat
53. Dopamine transporter ligand binding domains. Structural and functional properties revealed by limited proteolysis
54. Relationship between subjective effects of cocaine and dopamine transporter occupancy
55. Relationship between catechol substrate binding and amphetamine, cocaine and mazindol binding sites in a kinetic model of the striatal transport of dopamine in vitro
56. The vesicular monoamine transporter, in contrast to the dopamine transporter, is not altered by chronic cocaine self-administration in the rat
57. Addictive drugs and brain stimulation reward
58. Neurobiology of cocaine abuse